Allergy Therapeutics PLC (LSE:AGY) - Share price

Stock Report

Allergy Therapeutics PLC AGY

Cash Flow
Fiscal Year Ends30/06/201530/06/201630/06/201730/06/201830/06/2019
Operating Cash Flow3.30-11.931.28-4.175.38
Investing Activities-2.67-1.49-1.94-2.50-3.35
Net Outflow/Inflow0.46-13.33-1.77-6.312.25
Net Change in Cash20.54-0.79-1.95-6.6011.79
Foreign Exchange Adjustments-1.373.000.670.010.12
Opening Balance2.0321.2023.4122.1215.53
Closing Balance21.2023.4122.1215.5327.44
Investment Ratios
Cash Flow PS p0.63-2.080.03-0.610.84
CAPEX PS p-0.22-0.22-0.29-0.35-0.46

GBP in Millions except per share data.

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.